Franz Hefti - CEO @ Prevail Therapeutics - Crunchbase Person Profile

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Person)

63,355

Primary Job Title CEO
Primary Organization
Prevail Therapeutics

Location New York, New York, United States
Regions Greater New York Area, East Coast, Northeastern US
Gender Male

LinkedIn View on LinkedIn

Franz Hefti is the CEO of Prevail Therapeutics and he holds a Ph.D. from the University of Zurich and completed his postdoctoral research at the Massachusetts Institute of Technology.

Jobs

Number of Current Jobs

Number of Past Jobs

Franz Hefti

has

current jobs as

CEO

Prevail Therapeutics

and

Director

Cognition Therapeutics

. Additionally,

Franz Hefti

has had

past jobs including

Chief Development Officer

Prevail Therapeutics

Prevail Therapeutics CEOMar 2021
Cognition Therapeutics Director

Organization Name	Title At Company	Start Date	End Date
Prevail Therapeutics	Chief Development Officer	Mar 2018	Feb 2021
Proclara Biosciences	Interim CEO, President and Chief Operations Officer	Jun 2014	Dec 2017
Acumen Pharmaceuticals	Past CEO & President	Nov 2011	Jan 2015
Genentech	Executive Vice President of Drug Development	—	—
Rinat Neuroscience	Executive Vice President of Drug Development	—	—
University of Miami	Associate Professor	—	—
Merck	Senior Vice President of Neuroscience Research	—	—
University of Southern California	Professor	—	—
Avid Radiopharmaceuticals	Chief Scientific Officer	—	—
Genentech	Director of the Neuroscience Research Department	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Franz Hefti

holds

board and advisor roles as

Strategic Advisory Board

Alcyone Lifesciences

and

Boards of Directors

Asceneuron

Alcyone Lifesciences Strategic Advisory Board
Asceneuron Boards of Directors

Related Hubs

Hub Name	CB Rank (Hub)
City of New York Companies With Fewer Than 100 Employees (Top 10K)	2,779
Therapeutics Acquired Companies With Less Than $1B in Revenue	101,616
Health Diagnostics Companies With Less Than $500M in Revenue (Top 10K)	9,411
Northeastern US Health Care Acquired Companies	18,876
New York Biotechnology Companies	25,915
Northeastern US Acquired Companies With Less Than $10M in Revenue	10,129
City of New York Acquired Companies With Less Than $1B in Revenue	18,561
New York Acquired Companies With More Than 50 Employees	6,989
Companies that Went Public in 2019	42,637
New York Health Care Companies (Top 10K)	8,848